Election 2026

The November 3 election will reshape legislatures. Stay current on every seat, staff, and committee change with GovBuddy.

Stay Current
Home/Bills/A 2514New York · 2025–2026 Legislative Session
Assembly BillIntroduced

A 2514: Authorizes pharmacists to administer injections for contraceptive use.

New York · Assembly · 2025–2026 Legislative Session · last verified June 2, 2026

What A 2514 does, verified June 2, 2026

The bill aims to expand access to reproductive healthcare in New York State. Pharmacists will be authorized to administer injections for contraceptive use, including reversible progestin-only contraceptive injections. Pharmacists will need to receive training and provide patients with risk assessments and fact sheets before administering the injections. Pharmacists will also notify patients' primary healthcare practitioners within 72 hours of dispensing or administering the injections. The bill allows pharmacists to refuse to dispense or administer the injections if they deem it potentially harmful to the patient. The law will take effect one year after it becomes a law, and the state will establish rules and regulations necessary for implementation.

Bill journey
1IntroducedCurrent
2In CommitteePending
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: referred to higher education (2026-01-07)Alert me
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlock
Coauthors
Michael BenedettoAl TaylorSteven OtisAndrew HevesiRebecca SeawrightCarrie WoernerTony SimoneJessica González-RojasDavid WeprinDana LevenbergSarah ClarkPhil Steck
Recent actions2 total · showing 2
Jan. 07, 2026referred to higher education
Jan. 17, 2025referred to higher education
Latest bill textIntroduced version, January 17, 2025 · 1,067 words
  
  STATE OF NEW YORK ________________________________________________________________________ 2514 2025-2026 Regular Sessions  IN ASSEMBLY January 17, 2025 ___________ Introduced by M. of A. McDONALD, HEVESI, SEAWRIGHT, WOERNER, SIMONE, GONZALEZ-ROJAS -- read once and referred to the Committee on Higher Education AN ACT to amend the education law and the public health law, in relation to authorizing pharmacists to administer injections for contraceptive use The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 11 of section 6527 of the education law, as 2 added by chapter 128 of the laws of 2023, is amended to read as follows: 3 11. A licensed physician may prescribe and order a non-patient specif- 4 ic order to a pharmacist licensed and located in the state, pursuant to 5 regulations promulgated by the commissioner, and consistent with section 6 sixty-eight hundred one of this title, for dispensing self-administered 7 hormonal contraceptives or administering a United States Food and Drug 8 Administration approved reversible progestin-only contraceptive 9 injection as defined in section sixty-eight hundred two of this title. 10 § 2. Subdivision 9 of section 6801 of the education law, as added by 11 chapter 128 of the laws of 2023, is amended to read as follows: 12 9. a. A licensed pharmacist may execute a non-patient specific order 13 for the dispensing of self-administered hormonal contraceptives or 14 administer a United States Food and Drug Administration reversible 15 progestin-only contraceptive injection prescribed or ordered by the 16 commissioner of health, a physician licensed in this state or a nurse 17 practitioner certified in this state pursuant to rules and regulations 18 promulgated by the commissioner. 19 b. Prior to dispensing self-administered hormonal contraceptives or 20 administering a United States Food and Drug Administration reversible 21 progestin-only contraceptive injection to a patient, and at a minimum of 22 every twelve months for each returning patient, the pharmacist shall: EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD03405-01-5 

 A. 2514 2 1 (i) provide the patient with a self-screening risk assessment ques- 2 tionnaire, developed by the commissioner of health in consultation with 3 the commissioner, to be reviewed by the pharmacist to identify any known 4 risk factors and assist the patient's selection of an appropriate self- 5 administered hormonal contraceptive or United States Food and Drug 6 Administration reversible progestin-only contraceptive injection; and 7 (ii) provide the patient with a fact sheet, developed by the commis- 8 sioner of health, that includes but is not limited to, the clinical 9 considerations and recommendations for use of the self-administered 10 hormonal contraceptive or administration of a United States Food and 11 Drug Administration reversible progestin-only contraceptive injection, 12 the appropriate method for using such hormonal contraceptive, informa- 13 tion on the importance of follow-up health care, health care referral 14 information, and the ability of the patient to opt out of practitioner 15 reporting requirements. 16 c. No pharmacist shall dispense self-administered hormonal contracep- 17 tives or administer a United States Food and Drug Administration 18 reversible progestin-only contraceptive injection under this subdivision 19 without receiving training satisfactory to the commissioner. 20 d. A pharmacist shall notify the patient's primary health care practi- 21 tioner, unless the patient opts out of such notification, within seven- 22 ty-two hours of dispensing a self-administered hormonal contraceptive or 23 administration of a United States Food and Drug Administration revers- 24 ible progestin-only contraceptive injection, that such self-administered 25 hormonal contraceptive or United States Food and Drug Administration 26 reversible progestin-only contraceptive injection has been dispensed or 27 administered. If the patient does not have a primary health care prac- 28 titioner, or is unable to provide contact information for their primary 29 health care practitioner, the pharmacist shall provide the patient with 30 a written record of the contraceptives dispensed, and advise the patient 31 to consult an appropriate health care practitioner. 32 e. Nothing in this subdivision shall prevent a pharmacist from refus- 33 ing to dispense a non-patient specific order of self-administered 34 hormonal contraceptive or administration of a United States Food and 35 Drug Administration reversible progestin-only contraceptive injection 36 pursuant to this subdivision if, in their professional judgment, poten- 37 tial adverse effects, interactions or other therapeutic complications 38 could endanger the health of the patient. 39 § 3. Section 6802 of the education law is amended by adding a new 40 subdivision 31 to read as follows: 41 31. "United States Food and Drug Administration reversible proges- 42 tin-only contraceptive injection" for the purposes of section sixty- 43 eight hundred one of this article, means a pharmacist administered 44 reversible progestin-only contraceptive injection approved by the United 45 States Food and Drug Administration to prevent pregnancy by using 46 hormones to regulate or prevent ovulation. 47 § 4. Subdivision 11 of section 6909 of the education law, as added by 48 chapter 128 of the laws of 2023, is amended to read as follows: 49 11. A certified nurse practitioner may prescribe and order a non-pa- 50 tient specific order to a pharmacist licensed and located in the state, 51 pursuant to regulations promulgated by the commissioner, and consistent 52 with section sixty-eight hundred one of this title, for dispensing self- 53 administered hormonal contraceptives or administration of a United 54 States Food and Drug Administration approved reversible progestin-only 55 contraceptive injection as defined in section sixty-eight hundred two of 56 this title. 

 A. 2514 3 1 § 5. The public health law is amended by adding a new section 267-c to 2 read as follows: 3 § 267-c. Pharmacist administered reversible progestin-only contracep- 4 tive injections. The commissioner is authorized to establish a non-pa- 5 tient specific order, consistent with section sixty-eight hundred one of 6 the education law, for dispensing and for the administration of United 7 States Food and Drug Administration reversible progestin-only contra- 8 ceptive injection as defined in section sixty-eight hundred two of such 9 chapter. 10 § 6. This act shall take effect one year after it shall have become a 11 law. Effective immediately, the addition, amendment and/or repeal of any 12 rule or regulation necessary for the implementation of this act on its 13 effective date are authorized to be made and completed on or before such 14 effective date. 

Text of A 2514 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions
GovBuddy Demo

See how GovBuddy fits your team.

Share a few details and our team will follow up with a focused walkthrough.